Baker Biotech Capital (GP), LLC's Net Worth

$376 Million

Estimate Recalculated Feb 16, 2024 12:54PM EST

Who is Baker Biotech Capital (GP), LLC?

Baker Biotech Capital (GP), LLC has an estimated net worth of $376 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, XOMA Corp, AP PHARMA INC /DE/, BIOCRYST PHARMACEUTICALS INC, INCYTE CORP, IDERA PHARMACEUTICALS, INC., VIROPHARMA INC, SYNAGEVA BIOPHARMA CORP, GENOMIC HEALTH INC, ADOLOR CORP, AUXILIUM PHARMACEUTICALS INC, PHARMACYCLICS INC, ALLOS THERAPEUTICS INC, VAXGEN INC, TRANZYME INC, Synvista Therapeutics, Inc., Ardea Biosciences, Inc./DE, and NEUROGEN CORP.

SEC CIK

Baker Biotech Capital (GP), LLC's CIK is 0001244389

Past Insider Trading and Trends

2008 was Baker Biotech Capital (GP), LLC's most active year for acquiring shares with 87 total transactions. Baker Biotech Capital (GP), LLC's most active month to acquire stocks was the month of November. 2007 was Baker Biotech Capital (GP), LLC's most active year for disposing of shares, totalling 43 transactions. Baker Biotech Capital (GP), LLC's most active month to dispose stocks was the month of January. 2009 saw Baker Biotech Capital (GP), LLC paying a total of $3,276,016,673.65 for 36,608,139 shares, this is the most they've acquired in one year. In 2009 Baker Biotech Capital (GP), LLC cashed out on 19,670,077 shares for a total of $1,836,201,132.49, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SEATTLE GENETICS INC /WA (SGEN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+7.34%
339.79K
$6.25
$2,123,675.00
4.97M
Dec 30
Form 4
+6.28%
273.4K
$10.75
$2,939,093.00
4.63M
Aug 11
Form 4
+9.51%
378.05K
$9.72
$3,674,675.16
4.35M
May 20
Form 4
+1.06%
41.67K
$7.90
$328,962.77
3.97M
Mar 17 - Mar 18
Form 4
+1.68%
65K
$8.04
$522,325.26
3.93M
Mar 12 - Mar 14
Form 4
+0.90%
34.65K
$9.01
$312,376.79
3.87M
Feb 7 - Feb 11
Form 4
+17.79%
578.92K
$8.99
$5,206,045.65
3.83M
Jan 18 - Jan 22
Form 4
+182.21%
2.1M
3.25M
Jul 9
Form 4/A
-24.92%
-382.78K
$8.76
-$8,758,090.32
1.15M
Feb 14
Form 4
-24.92%
-382.78K
$8.72
-$8,718,099.04
1.15M
Feb 14
Form 4
+0.79%
12.08K
$4.05
$48,924.00
1.54M
Aug 14
Form 4/A
+4.65%
66.07K
$4.05
$267,589.15
1.49M
Aug 8 - Aug 9
Form 4
+2.41%
35.92K
$4.03
$144,716.54
1.52M
Aug 10 - Aug 11
Form 4/A
+1.51%
21.19K
$4.03
$85,339.64
1.42M
Aug 3 - Aug 7
Form 4
+0.55%
7.68K
$3.70
$28,419.42
1.4M
Aug 2
Form 4
+4.67%
66.07K
$4.05
$267,589.15
1.48M
Aug 8 - Aug 9
Form 4
+1.52%
21.19K
$4.03
$85,339.64
1.41M
Aug 3 - Aug 7
Form 4
+10.29%
129.98K
$4.03
$524,022.00
1.39M
Jun 27 - Jun 29
Form 4
+4.17%
50.53K
$4.02
$203,199.88
1.26M
Jun 22 - Jun 26
Form 4
+3.26%
38.23K
$4.02
$153,696.91
1.21M
Jun 19 - Jun 21
Form 4
+75.98%
507.02K
$4.00
$2,030,072.61
1.17M
Jun 9 - Jun 13
Form 4
+71.70%
278.65K
$5.25
$1,462,912.50
667.29K
May 24
Form 4
+1.90%
7.24K
$4.79
$34,682.22
388.64K
May 4
Form 4
+30.61%
89.39K
$4.00
$357,559.72
381.4K
Apr 29
Form 4
+4.30%
12.04K
$4.96
$59,748.50
292K
Mar 30
Form 4
+3.81%
10.27K
$4.88
$50,093.90
279.96K
Mar 28 - Mar 29
Form 4
+164.62%
167.77K
$4.99
$837,977.95
269.69K
Mar 22 - Mar 23
Form 4
+55.09%
32.72K
$5.55
$181,508.95
92.12K
Aug 10 - Aug 12
Form 4
+53.63%
20.73K
$5.53
$114,719.19
59.4K
Aug 5 - Aug 6
Form 4
38.66K
$5.72
$221,337.19
38.66K
Aug 2 - Aug 4
Form 3
0
0
No matching records found

XOMA Corp (XOMA) Snapshot price: $20.98

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

AP PHARMA INC /DE/ (HRTX) Snapshot price: $2.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 3
0
0
No matching records found

BIOCRYST PHARMACEUTICALS INC (BCRX) Snapshot price: $5.3075

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.45%
-236.48K
$4.22
-$998,291.85
1.52M
May 28 - Jun 1
Form 4
+6.56%
108.2K
$0.99
$107,306.59
1.76M
Nov 20 - Nov 24
Form 3
0
0
No matching records found

INCYTE CORP (INCY) Snapshot price: $57.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-11.92%
-397.05K
$14.88
-$5,906,851.32
2.93M
Sep 21 - Sep 23
Form 4
-4.50%
-156.93K
$14.06
-$2,207,205.49
3.33M
Aug 9 - Aug 10
Form 4
0
0
Sep 24
Form 4
+0.10%
3.45K
$2.15
$7,401.94
3.49M
Mar 3 - Mar 5
Form 4
+0.22%
7.7K
$2.15
$16,579.85
3.48M
Feb 26 - Mar 2
Form 4/A
+7.00%
227.28K
$3.50
$796,589.77
3.48M
Dec 17 - Dec 22
Form 4
+7.00%
227.27K
$3.50
$796,550.77
3.48M
Dec 17 - Dec 19
Form 4
+6.62%
201.65K
$9.00
$1,814,832.00
3.25M
Jul 31
Form 4
+0.00%
65
$10.62
$690.30
3.05M
Jan 22
Form 4
+0.45%
13.68K
$10.99
$150,254.06
3.05M
Jan 14
Form 4
+1.62%
48.39K
$10.94
$529,506.62
3.03M
Jan 9 - Jan 11
Form 4
+15.14%
392.57K
$10.14
$3,981,174.89
2.98M
Jan 4 - Jan 8
Form 4
+3.76%
93.85K
$10.60
$994,552.11
2.59M
Dec 17 - Dec 19
Form 4/A
+7.36%
171.2K
$9.99
$1,710,056.16
2.5M
Dec 10 - Dec 12
Form 4
+7.36%
171.2K
$9.99
$1,710,056.16
2.5M
Dec 10 - Dec 12
Form 4
+0.85%
19.59K
$8.98
$175,980.41
2.33M
Dec 4
Form 4
+0.75%
17.13K
$8.68
$148,696.87
2.31M
Nov 29 - Dec 3
Form 4
+3.30%
73.26K
$8.11
$594,059.86
2.29M
Nov 26 - Nov 28
Form 4
+3.30%
70.74K
$8.18
$579,008.51
2.22M
Nov 19 - Nov 21
Form 4
+6.24%
126.1K
$8.50
$1,071,955.15
2.15M
Nov 14 - Nov 16
Form 4
+4.81%
274.18K
$8.17
$2,217,012.10
5.97M
Nov 9 - Nov 13
Form 4
+10.88%
171.33K
$4.91
$840,553.69
1.75M
Aug 1 - Aug 3
Form 4/A
0
0
Feb 19
Form 4
0
0
Feb 19
Form 4
+2.33%
67.3K
$4.93
$334,506.98
2.96M
Sep 22
Form 4
+59.31%
526K
$5.04
$2,649,672.40
1.41M
Sep 19
No matching records found